Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

New York, New York 10032


Many post Acute Coronary Syndrome(ACS) patients do not take their medications (including aspirin) as prescribed, leading to an increase in mortality. Patients enrolled in this study will be enrolled into one of two groups. Patients in the first group will have their medication adherence measured, but will receive all other care as usual. Patients in the second group will also have their medication adherence measured, but they will receive telephone-delivered problem solving therapy (PST) in addition to their usual care. The two groups will be combined to determine the Minimally Effective Dose (MED) and the Maximally Tolerated Dose (MTD) for adherence to aspirin. The medication adherence of the PST group will improve by 20% (<55% to >75%).


Inclusion Criteria: 1. Medical eligibility: 1. Patient presenting for staged intervention with positive cardiac history OR 2. Patient with stable CAD who received cardiac admission but does not report chest pain. OR 3. Patient with stable CAD who has had a cardiac admission in the past. 2. Patient is non-adherent to prescribed medication. The following exclusion criteria have been set for either safety concerns or concerns that patients will not be able to complete the protocol: 1. inability to communicate in English or Spanish 2. unwilling to be randomized or to have aspirin in a separate bottle if they use a pill box 3. unavailability for the 1 month period of the study (including being unavailable by phone and/or traveling out of the country) 4. medically unable to receive aspirin (e.g. allergy, contra-indicated, etc) 5. deemed unable to comply with the protocol (either self selected or by indicating during screening that s/he could not complete all requested tasks). This includes patients with a level of cognitive impairment indicative of dementia, and patients with current alcohol or substance abuse. 6. deemed to need immediate psychiatric assessment (e.g., must be hospitalized, or have some other psychiatric intervention conducted within 72 hours). 7. active psychosis, bipolar disorder, or any overt personality disorder



Primary Contact:

Principal Investigator
Karina W. Davidson, PhD
Columbia University

Backup Contact:


Location Contact:

New York, New York 10032
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: June 25, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.